SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

ALS-FTD-Parkinsonism Comparison Matrix

active
wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-als-ftd-parkinsonism-compa
Related Entities
diseases-als-ftd-parkinsonism-comparison
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
61
Outgoing
120
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (181)
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di75%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD75%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes75%
mentions🔬RNA binding protein dysregulation across ALS FTD AD75%
mentions🔬How do non-cell autonomous effects of autophagy dysfunction 75%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin70%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio70%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
mentions🧫Metabolic Pathway-Targeted Therapy in ALS70%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples70%
mentions🧫Experiment Scoring Methodology70%
related🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS70%
mentions🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto70%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model70%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
related🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫TDP-43 mutant mouse model cGAS/STING pathway analysis70%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design70%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk70%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP70%
mentions🧫Brainstem Circuit Modulation for PSP70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker70%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
mentions🧫cGAS/STING pathway activation by TDP-43-released mtDNA70%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%
mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen70%
mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%
mentions🧫Experiment Index70%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic70%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen70%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes67%
related🔬How do non-cell autonomous effects of autophagy dysfunction 67%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di67%
related🔬RNA binding protein dysregulation across ALS FTD AD67%
related🔬RNA binding protein dysregulation across ALS FTD and AD67%
mentions🧪R-Loop Resolution Enhancement Therapy65%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫cGAS/STING pathway activation by TDP-43-released mtDNA63%
related🧫s:** - Temporal analysis showing mitochondrial defects prece63%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen63%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic63%
related🧫Experiment Scoring Methodology63%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples63%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%
related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto63%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study63%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio63%
related🧫Brainstem Circuit Modulation for PSP63%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka63%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des63%
related🧫N-of-1 Clinical Trial Design for CBS/PSP63%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD63%
related🧫TDP-43 PET Ligand Development for FTD and ALS63%
related🧫Experiment Index63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫Metabolic Pathway-Targeted Therapy in ALS63%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin63%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen63%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model63%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker63%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples63%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design63%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%
related🧫TDP-43 mutant mouse model cGAS/STING pathway analysis63%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk63%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧪R-Loop Resolution Enhancement Therapy58%
mentions🧪TREM2-mediated microglial tau clearance enhancement55%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination55%
related🔬What are the mechanisms underlying rna binding protein dysre54%
related🔬What are the mechanisms underlying tdp-43 phase separation t54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧪Lysosomal Membrane Repair Enhancement50%
related🧪Mitochondrial RNA Granule Rescue Pathway50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪Extracellular Matrix Stiffness Modulation50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧪Cross-Seeding Prevention Strategy50%
related🧪Lysosomal Calcium Channel Modulation Therapy50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
related🧪Mitochondrial Transfer Pathway Enhancement50%
related🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
related🧪Phase-Separated Organelle Targeting50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy50%
related🧪CX43 hemichannel engineering enables size-selective mitochon50%
related🧪Stress Granule Phase Separation Modulators50%
related🧪Serine/Arginine-Rich Protein Kinase Modulation50%
related🧪RNA Granule Nucleation Site Modulation50%
mentions🧪Cryptic Exon Silencing Restoration50%
related🧪Axonal RNA Transport Reconstitution50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🧪Mitochondrial-Lysosomal Contact Site Engineering50%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim50%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬What are the mechanisms underlying protein aggregation cross50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia50%
mentions🧪APOE-Dependent Autophagy Restoration50%
related🧪Senescent Cell Mitochondrial DNA Release50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🧪Lysosomal Positioning Dynamics Modulation50%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🧪Mitochondrial SPM Synthesis Platform Engineering50%
mentions🧪APOE-TREM2 Interaction Modulation50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation44%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers44%
mentions🧫Tau depletion effects on neuronal development in primary cul44%
mentions🧫Microtubule domain analysis in adult axons44%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
related🧪Extracellular Matrix Stiffness Modulation40%
related🧪Cross-Seeding Prevention Strategy40%
related🧪Cryptic Exon Silencing Restoration40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub